021-51111890
购物车（）
sales@molnova.cn
Chrysophanol triglucoside
CAS No. 120181-07-9
Chrysophanol triglucoside ( 大黄酚-1-O-β-三葡萄糖苷 )
产品货号. M38843 CAS No. 120181-07-9
Chrysophanol triglucoside 是一种从决明子中分离出的蒽醌类化合物，可抑制蛋白酪氨酸磷酸酶 1B (PTP1B) 和 α-glucosidase，IC50 值分别为80.17 和 197.06 μM。Chrysophanol triglucoside 具有糖尿病研究的潜力。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥3126 | 有现货 |
|
| 25MG | 获取报价 | 有现货 |
|
| 50MG | 获取报价 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Chrysophanol triglucoside
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Chrysophanol triglucoside 是一种从决明子中分离出的蒽醌类化合物，可抑制蛋白酪氨酸磷酸酶 1B (PTP1B) 和 α-glucosidase，IC50 值分别为80.17 和 197.06 μM。Chrysophanol triglucoside 具有糖尿病研究的潜力。
-
产品描述Chrysophanol triglucoside is an anthraquinone isolated from Cassia obtusifolia, inhibits protein tyrosine phosphatases 1B (PTP1B) and α-glucosidase with IC50s of 80.17 and 197.06 μM, respectively. Chrysophanol triglucoside has the potential for diabetes research.
-
体外实验———
-
体内实验———
-
同义词大黄酚-1-O-β-三葡萄糖苷
-
通路Others
-
靶点Other Targets
-
受体IC50: 80.17 μM (PTP1B), 197.06 μM (α-glucosidase)
-
研究领域———
-
适应症———
化学信息
-
CAS Number120181-07-9
-
分子量740.664
-
分子式C33H40O19
-
纯度>98% (HPLC)
-
溶解度———
-
SMILES———
-
化学全称———
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
Hydroxytuberosone
Hydroxytuberosone is a natural product from Pueraria lobata.
-
D-Saccharic acid 1,4...
D-Saccharic Acid 1,4-lactone Hydrate 是一种有效的 β-葡萄糖醛酸酶抑制剂 (IC50=48.4 μM)。 D-糖二酸1,4-内酯水合物具有抗癌、解毒和抗氧化特性。
-
Chitinase, Serratia ...
Chitinase, Serratia marcescens (EC 3.2.1.14) has partial lysozyme activity and is widely found in bacteria, fungi, animals and some plants. Chitinase belongs to the glycosyl hydrolase family. Chitinase catalyzes chito-oligosaccharide hydrolysis. Chitinases also can serve as prognostic biomarkers of disease progression. Chitinase can be used in the research of pathogenesis of various human fibrotic and inflammatory disorders, particularly those of the lung (idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, sarcoidosis, and asthma) and the gastrointestinal tract (inflammatory bowel diseases (IBDs) and colon cancer).
